Introduction: The applicability of "Rubidium Chloride, 82 Rb from Generator" radiop-
| INTRODUC TI ON
The references of using 82 Sr/ 82 Rb generator ( 82 Rb generator)
for positron-emission tomography (PET) dates back to the 70 s (Kulprathipanja, Hnatowich, & Ben, 1979; Yano & Roth, 1979) .
Generator for clinical use based on hydrated tin oxide were developed in the USA (Neidrickx, 1980) , the UK (Waters, Horlock, & Kensett, 1983) , Switzerland (Beyer, Rӧsch, & Ravn, 1990) , Canada (Cackette, Ruth, & Vincent, 1993) , Russia (Kodina, Kurenkov, Kurchatova, Malinin, & Yu, 1991; Litvinov et al., 1997) , and Korea (Jeong et al., 1994) . At present, the 82 Rb-generators are mainly Moscow) with the participation of TRIUMF (Vancouver, Canada) (Chudakov et al., 2005 (Chudakov et al., , 2014 Chudakov, Zhuikov, & Kokhanuk, 2015) . A new approach The generator-produced radiopharmaceutical has an important advantage: it does not require a complicated and expensive cyclotron-radiochemical complex.
Due to a short half-life of 82 Rb (76 s), the absorbed dose of radiation is low for a patient. It gives the opportunity to repeat testing many times as well as to use several radiopharmaceuticals successively within one day for the same patient.
Earlier the generator was used almost in cardiology only (Chatal et al., 2015) . The first study of brain tumors perfusion of using PET with 82 Rb-chloride was carried out in 1980-90 s (Brooks et al., 1984; Roelcke et al., 1996; Yen et al., 1982) . The attention was paid to 82 Rb + property to penetrate the blood-brain barrier (BBB).
In particular, some authors studied 82 Rb-chloride diagnostic capabilities during the estimation of blood-brain barrier permeability in patients with glial tumors and metastatic brain lesions (Brooks et al., 1984) . The obtained results showed the capacity of 82 Rb-chloride to higher uptake in the areas with a damaged blood-brain barrier. The diagnostic accuracy of the method was similar to the data of the perfusion X-ray computed tomography (PCT) and magnetic resonance perfusion imaging (MRI). cations into the brain tumor cells (Brooks et al., 1984) .
The interest in 82 Rb-chloride as a tumor-seeking radiopharmaceutical rose 2010-2011 due to the active application of the new multimodal device PET-CT in the routine clinical practice (Kale, Halkar, & Galt, 2007; Khandani, Sheikh, Beavers, & Ivanovic, 2010; Mirpour & Khandani, 2011) . So far, there are few reports (Brooks et al., 1984; Kale et al., 2007; Khandani et al., 2010; Mirpour & Khandani, 2011; Roelcke et al., 1996; Yen et al., 1982) The application of diagnostics with 82 Rb-chloride may be an important independent method in PET investigation of brain, or, in particular, a complementary method to ordinary approaches (Bell et al., 2015; Herholz, 2017) using compounds with 18 F, 11 C, and 13 N, especially in combination with cardiological application of the same generator.
The goal of the current research is obtaining more data with 82 Rb PET in combination with FDG PET and different diagnostic methods (CT, MRI and angiography). The present study is a pilot study, and more data need to be accumulated.
| E XPERIMENTAL
The procedures followed were performed in accordance with the provided written informed consent prior to participation in this study. 82 Rb-generator GR-01 with package design and 82 Rb elution system scheme is shown in Figure 1 . The generator described in details in (Chudakov et al., 2014) consists of a generator column encased in a shielding container made of tungsten and steel ( Figure 1a ). Figure 1b ). The scheme of elution system is shown in Figure 1c (the blue arrow indicates the saline flow direction, and the red arrows indicate the flow direction of eluate with 82 Rb-chloride). A minimum time to perform sequential imaging in studies of patients is 15 min. 
(VD) were estimated, and activity/time curves for tumors and normal brain cortex areas were plotted. UI is a ratio between maximal activity value accumulated in zone of interest of the tumor and maximal activity value in the zone of interest of the intact brain tissue.
VD is a ratio between maximal activity value accumulated in zone of
interest of the tumor and maximal activity value in the normal cortex of the vascular phase.
A total of 21 patients at the age of 18-76 with different brain tumors were examined. All the patients underwent PET examination with 82 Rb-chloride along with MRT with contrast agent, and some patients underwent PET examination with 18 F-FDG, CT along with brain X-ray angiography.
| RE SULTS AND D ISCUSS I ON S
In 14 of total amount, 21 patients (67%) brain tumors were diagnosed. In 10 of 14 patients, malignant tumors (8 glioblastoma and 2 meningioma) were diagnosed. In other 4 of 14 patients, the benign brain tumors (3 astrocytoma and 1 meningioma) were diagnosed. In 3 of 21 patients, postsurgical cysts and in 4 patients arteriovenous malformations were diagnosed.
In all 10 cases, malignant tumors (glioblastoma and meningioma)
were exactly visualized at PET examination with 82 Rb-chloride. In all the cases, abnormal focuses of radiopharmaceutical high uptake were detected in the image of a tumor node (Figures 2, 3) . Activity/ time curves plotted over malignant tumors images (Figure 2) show for high vascularization of the malignant tumors along with pathological permeability of cell membranes of the tumor blood vessels as compared to intact brain cortex. It is noteworthy that as a rule, monotonic increase in radiopharmaceutical's uptake in malignant glioma and meningioma was detected during the whole scan session (11 min) (Figures 2, 3 ).
Earlier in (Granov et al., 1997 (Granov et al., , 2011 (Granov et al., , 2012 , we demonstrated that optimal time for PET scanning with 82 Rb-chloride is 11 min.
Along with this, in order to obtain correct activity/time curves the radiopharmaceutical should be administrated during 11-16 s which is faster than in (Roelcke et al., 1995) (30-60 s when scanning time is 6 min).
Radiopharmaceutical uptake in the tumor node appeared to be low in 3 patients with astrocytoma of a low malignant potential (Figure 4 ). Tumor imaging in such cases became possible entirely due to the far lower uptake of 82 Rb-chloride in intact brain cortex, and due to this fact, tumors were partially seen ( Figure 4) . As a rule, within the tissue phase monotonic radiopharmaceutical elimination was observed or radiopharmaceutical content remained at low level.
At the same time, high radiopharmaceutical uptake in the tumor was detected in both vascular and tissue phases in the patient with benign meningioma, and this fact may be explained by high vascularization of meningioma. Radiopharmaceutical uptake in postsurgical cysts after tumor eradication was close to its background absorption. Cysts were not visualized on the background of radiopharmaceutical low uptake in the brain cortex.
In patients with arteriovenous malformation (AVM), high 82 Rbchloride uptake was detected only in the vascular phase and it was low in the tissue phase ( Figure 5 ).
An uptake index UI (ratio 82 Rb-uptake in tumor/ 82 Rb-uptake in normal brain tissue) was estimated in order to carry out the quantification of obtained data. Obtained results of the radiopharmaceutical uptake level in the examined masses are shown in Table 1 .
The data represented in Table 1 Note. UI is a ratio between maximal activity value accumulated in zone of interest of the tumor and maximal activity value in the zone of interest of the intact brain tissue. VD is a ratio between activity value accumulated in region of interest in the tumor and activity value in the intact brain tissue of vascular phase.
| CON CLUS ION
tumor and nontumor lesions, such as AVM, in human brain with low radiation effective doses (1.0-1.9 mSv). 
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